![Wendy Blosser](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Wendy Blosser
Algemeen Directeur bij ACCUSTEM SCIENCES, INC.
Vermogen: 940 $ op 31-05-2024
Profiel
Wendy Blosser is currently the Chief Executive Officer & Director at AccuStem Sciences, Inc. She previously held positions as Vice President-Sales at Integrated Oncology Solutions, Inc., Chief Commercial Officer at Biodesix, Inc., and Chief Commercial Officer at Agendia, Inc. From 2019 to 2021, she served as the Chief Commercial Officer at Agendia NV.
Ms. Blosser completed her undergraduate degree at Marietta College and her graduate degree at West Virginia University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
ACCUSTEM SCIENCES INC
0.02% | 31-12-2023 | 2 000 ( 0.02% ) | 940 $ | 31-05-2024 |
Actieve functies van Wendy Blosser
Bedrijven | Functie | Begin |
---|---|---|
ACCUSTEM SCIENCES, INC. | Algemeen Directeur | 04-03-2022 |
Eerdere bekende functies van Wendy Blosser
Bedrijven | Functie | Einde |
---|---|---|
Agendia NV
![]() Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Corporate Officer/Principal | 01-03-2021 |
Agendia, Inc.
![]() Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Corporate Officer/Principal | - |
Integrated Oncology Solutions, Inc. | Verkoop & Marketing | - |
BIODESIX, INC. | Corporate Officer/Principal | - |
Opleiding van Wendy Blosser
Marietta College | Undergraduate Degree |
West Virginia University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
BIODESIX, INC. | Health Services |
ACCUSTEM SCIENCES, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Agendia, Inc.
![]() Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Health Technology |
Integrated Oncology Solutions, Inc. | |
Agendia NV
![]() Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Health Services |